{"slideshow_credits": null, "snippet": "The drug was approved in 2012 for cancer patients, but has since become an outsize moneymaker for Insys Therapeutics and has been prescribed more widely.", "abstract": "Questions are being raised about off-label use of narcotic drug Subsys, form of fentanyl that is often used when painkillers like morphine fail to provide relief; drug was approved in 2012 for cancer patients, but has since become outsize moneymaker for Insys Therapeutics and has been prescribed more widely.", "section_name": "Business Day", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Katie", "role": "reported", "lastname": "THOMAS", "rank": 1, "organization": ""}], "original": "By KATIE THOMAS", "contributor": ""}, "web_url": "http://www.nytimes.com/2014/05/14/business/doubts-raised-about-off-label-use-of-subsys-a-strong-painkiller.html", "lead_paragraph": "The drug was approved in 2012 for cancer patients, but has since become an outsize moneymaker for Insys Therapeutics and has been prescribed more widely.", "headline": {"main": "Doubts Raised About Off-Label Use of Subsys, a Strong Painkiller", "print_headline": "Doubts Raised About Off-Label Use of a Painkiller"}, "_id": "5372b9fd38f0d82a8972517c", "word_count": "1442", "multimedia": [{"height": 126, "url": "images/2014/05/14/business/DRUG01/DRUG01-thumbWide-v2.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/05/14/business/DRUG01/DRUG01-thumbWide-v2.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2014/05/14/business/DRUG01/DRUG01-articleLarge-v2.jpg", "legacy": {"xlarge": "images/2014/05/14/business/DRUG01/DRUG01-articleLarge-v2.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/05/14/business/DRUG02/DRUG02-thumbStandard-v2.jpg", "legacy": {"thumbnail": "images/2014/05/14/business/DRUG02/DRUG02-thumbStandard-v2.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-05-14T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Cancer", "name": "subject", "is_major": "N", "rank": "5"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "N", "rank": "1"}, {"value": "Pain-Relieving Drugs", "name": "subject", "is_major": "Y", "rank": "3"}, {"value": "Insys Therapeutics Inc.", "name": "organizations", "is_major": "Y", "rank": "4"}, {"value": "Food and Drug Administration", "name": "organizations", "is_major": "N", "rank": "2"}], "blog": [], "subsection_name": null, "type_of_material": "News"}